Beta blocker for patients with pulmonary arterial hypertension: A single center experience.

[1]  P. Ho,et al.  Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. , 2014, JAMA internal medicine.

[2]  J. DiNicolantonio,et al.  Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis. , 2013, International journal of cardiology.

[3]  Zhi-Hong Liu,et al.  Echocardiographic Parameters in Patients with Pulmonary Arterial Hypertension: Correlations with Right Ventricular Ejection Fraction Derived from Cardiac Magnetic Resonance and Hemodynamics , 2013, PloS one.

[4]  F. Gaita,et al.  Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. , 2013, European heart journal.

[5]  D. Stewart,et al.  Usefulness of beta-blocker therapy and outcomes in patients with pulmonary arterial hypertension. , 2012, The American journal of cardiology.

[6]  Daniel F. Freitag,et al.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012, The Lancet.

[7]  W. Paulus,et al.  Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension , 2012, Circulation. Heart failure.

[8]  M. Ugander,et al.  Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease , 2011, Scandinavian journal of rheumatology.

[9]  N. Voelkel,et al.  Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. , 2010, American journal of respiratory and critical care medicine.

[10]  E. K. Weir,et al.  Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies , 2010, Circulation.

[11]  W. Paulus,et al.  Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart , 2010, European Respiratory Review.

[12]  M. Gatzoulis,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[13]  A. Branzi,et al.  A meta-analysis of randomized controlled trials in pulmonary arterial hypertension , 2008, European heart journal.

[14]  S. Rich,et al.  A USA-based registry for pulmonary arterial hypertension: 1982–2006 , 2007, European Respiratory Journal.

[15]  Martin J. Lohse,et al.  What Is the Role of &bgr;-Adrenergic Signaling in Heart Failure? , 2003, Circulation research.

[16]  R. Lefkowitz,et al.  Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. , 1998, Circulation.

[17]  M. Humbert,et al.  Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. , 2006, Gastroenterology.